ENTITY

MorphoSys AG (MOR US)

6
Analysis
Health Care • Germany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
more
Exchange Announcement • 21 Jun 2024 04:33

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 23 Mar 2024 04:45

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 16 Mar 2024 04:46

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 15 Mar 2024 04:52

SC14D9C | Written communication by the subject company relating to a third party tender offer

Exchange Announcement • 14 Mar 2024 05:22

SC14D9C | Written communication by the subject company relating to a third party tender offer

x